Immunosuppressive factors were isolated from culture fluids of DBA/2 mouse mastocytoma cells grown in serum-free RPMI-1640 medium by measurement of inhibitory activity on tritiated thymidine uptake of DBA/2 spleen cells responding to Escherichia coli lipopolisaccharide (LPS) and concanavalin A (ConA) and by comparison of the number of hemolytic antibody-forming cells in vitro after simultaneous addition of the factors with sheep red blood cells (SRBC). The culture fluids were separated into four fractions with immunosuppressive activities: F-I (mol wt, > 30,000), and F-II (mol. wt, 10,000-30,000), F-III (mol wt, 2,000-10,000), and F-IV (molwt, 700-2,000), F-IV specifically suppressed lymphocyte responses to E. coli LPS at concentrations of 50-200 microgram/ml. The other three fractions also showed immunosuppressive activities in both Con-A-induced and E. coli LPS-induced lymphocyte responses. The four fractions as well as crude culture fluids of mastocytoma cells expressed as immunosuppressive effect when injected into the peritoneal cavities of DBA/2 mice at doses of 24-180 microgram/day for 5 consecutive days. The fractions with a molecular weight equivalent to F-IV of mastocytoma culture supernatant were detected little, if any, in the supernatant from a nonmalignant cell culture. No suppressive effects of the fraction with a molecular weight greater than 2,000 (equivalent to F-I + F-II + F-III) from nonmalignant cell culture were found on lymphocyte responses to mitogens or SRBC at the concentrations used (100-200 microgram/ml).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jnci/65.4.759 | DOI Listing |
Vet Q
December 2024
Laboratory of Comparative and Translational Oncology, Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of São Paulo, Pirassununga, Brazil.
Mast cell tumours (MCTs) are common malignant neoplasms in dogs, for which prognosis and therapeutic decisions are based on histological features and proliferation markers. Autophagy is a cellular catabolic process responsible for degrading cytoplasmic components to maintain homeostasis, alterations in which are frequently linked to tumour growth and progression. This study was conducted to investigate the occurrence of autophagy in canine MCTs and to verify its value as a prognostic indicator for dogs with the disease.
View Article and Find Full Text PDFVet Comp Oncol
October 2024
Department of Veterinary Sciences, University of Turin, Turin, Italy.
Nodal metastasis is a negative prognostic factor in dogs with mast cell tumours (MCTs), thus early detection enables more informed decision-making and provides valuable prognostic information. The aim of this study is to assess the concordance between histopathologic findings of LNs and cytology and flow cytometry (FC), respectively, and to evaluate the ability of FC to differentiate between metastatic (HN2-HN3) and non-metastatic (HN0-HN1) LNs. Overall, 117 LNs from 64 dogs with first occurring MCTs were submitted for cytology, histology and FC.
View Article and Find Full Text PDFActa Vet Scand
October 2024
Cancer Research Institute Ghent, Medical Research Building, University Hospital Ghent, Salisburylaan 133, Merelbeke, 9820, Belgium.
Diagn Cytopathol
January 2025
Department of Dermatology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi University, New Delhi, Delhi, India.
Sci Rep
August 2024
Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
Immunotherapy is a promising alternative treatment for canine mast cell tumour (MCT). However, evasion of immune recognition by downregulating major histocompatibility complex (MHC) molecules might decline treatment efficiency. Enhancing MHC expression through interferon-gamma (IFN-γ) is crucial for effective immunotherapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!